Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Bath & Body Works (BBWI), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended October 2024.
Bath & Body Works looks to report a relatively weak Q3 due to persisting macroeconomic issues that pressure discretionary spending. Looking past short-term earnings issues, Bath & Body Works has a stable earnings outlook with well-built brand loyalty. The short-term earnings pressure has pushed the BBWI stock down too much, and I now estimate the stock to have a 52% upside into a fair value of $47.95.
Bath & Body Works (BBWI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Barclays analyst Adrienne Yih downgraded Bath & Body Works Inc BBWI from Equal-Weight to Underweight and lowered the price target from $31 to $28. The stock fell after the rerating.
Nike stock has tumbled in the face of recent challenges, but the pullback has created an opportunity for long-term investors. Bath & Body Works is generating plenty of cash and looks attractively valued.
BBWI is a market leader in a high-quality industry, yet it's trading as if it's going out of business. I expect BBWI to return to growth in 2025 by leaning into its loyal customer base, successful collaborations, and expansion into new product categories and international markets. If BBWI successfully returns to growth in 2025, I believe a multiple re-rating closer to industry peers is justified.
Bath & Body Works is undervalued, with a fair value estimate of $38 per share, offering a 32% upside from the current price. The company boasts strong brand loyalty, a robust omnichannel presence, and impressive operational efficiency, driving high returns on invested capital. Despite challenges like economic sensitivity and competition, BBWI's strategic initiatives and innovation position it well for continued growth.
I am neutral on Bath & Body Works Inc. due to a bleak near-term outlook and lack of positive growth catalysts. The stock is now at the low end of its 10-year trading range. Weak sales performance is expected due to cautious consumer spending, ineffective new product launches, and growing inventory levels potentially leading to markdowns.
Bath & Body Works, Inc. BBWI reported worse-than-expected second-quarter sales results and issued FY24 adjusted EPS guidance with its midpoint below estimates. Also, the company issued third-quarter EPS guidance below estimates.
It's been a tough year for Bath & Body Works NYSE: BBWI. So far, in 2024, the home fragrance, body care, and soap retailer founded in Columbus, Ohio, has seen its shares fall around 24%.
Bath & Body Works (BBWI) shares sank after the company slashed its 2024 guidance and missed expectations with its second-quarter sales.
Bath & Body Works, Inc. (NYSE:BBWI ) Q2 2024 Earnings Conference Call August 28, 2024 9:00 AM ET Company Participants Luke Long - Vice President, Investor Relations Gina Boswell - Chief Executive Officer and Director Julie Rosen - President Eva Boratto - Chief Financial Officer Conference Call Participants Simeon Siegel - BMO Capital Markets Lorraine Hutchinson - Bank of America Alex Straton - Morgan Stanley Kate McShane - Goldman Sachs Matthew Boss - JP Morgan Krisztina Katai - Deutsche Bank Dana Telsey - Telsey Advisory Group Olivia Tong - Raymond James Marni Shapiro - The Retail Tracker Jonna Kim - TD Cowen Korinne Wolfmeyer - Piper Sandler Operator Good morning. My name is Donna, and I will be your conference operator today.